Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction

Metabolism: Clinical and Experimental

Volumn 52, Issue 6, 2003, Pages 784-790

  Phillips, Gerald B ^a,b   Jing, Tianyi ^a,b   Heymsfield, Steven B ^a,b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ESTRADIOL; ESTRONE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; AGE; AGED; ARTICLE; BODY FAT; BODY MASS; BODY SIZE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENDER; HEART INFARCTION; HUMAN; HUMAN EXPERIMENT; LINEAR REGRESSION ANALYSIS; MALE; NORMAL HUMAN; OBESITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; SUBCUTANEOUS FAT; BLOOD; BODY CONSTITUTION; MIDDLE AGED; PATHOLOGY; VISCERA;

ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; BODY CONSTITUTION; BODY MASS INDEX; ESTRADIOL; HUMANS; INSULIN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; RISK FACTORS; TESTOSTERONE; VISCERA;

EID: 0038142240     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(03)00072-6     Document Type: Article

References (75)

1. Phillips GB: Sex hormones, risk factors and cadiovascular disease. Am J Med 65:7-11, 1978
2. Zavaroni I, Dall'Aglio E, Bonora E, et al: Evidence that multiple risk factors for conary artery disease exist in persons with abnormal glucose tolerance. Am J Med 83:609-612, 1987
3. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
4. Phillips GB: Relationship between serum sex hormones and glucose, insulin, and lipid abnormalities in men with myocardial infarction. Proc Natl Acad Sci USA 74:1729-1733, 1977
5. Meigs JB: Invited commentary: Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the in the fabric of correlated metabolic risk factors. Am J Epidemiol 152:908-911, 2000
6. Cigoloni M, Seidell JC, Targher G, et al: Fasting serum insulin in relation to components of the metabolic syndrome in European healthy men: The European fat distribution study. Metabolism 44:35-40, 1995
7. Maison P, Byrne CD, Hales CN, et al: Do different dimensions of the metabolic syndrome change together over time? Diabetes Care 24:1758-1763, 2001
8. Gallagher D, Kovera AJ, Clay-Williams G, et al: Weight loss in postmenopausal obesity: No adverse alterations in body composition and protein metabolism. Am J Physiol 279:E124-E131, 2000
9. Vermeulen A, Verdonck L, Kaufman JM: A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672, 1999
10. Sodergard R, Backstrom T, Shanbhag V, et al: Calculation of free and bound fractions of testerone and estradiol-7β to human plasma proteins at body temperature. J Steroid Biochem 16:801-810, 1982
11. Phillips GB: Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity. Metabolism 42:116-120, 1993
12. Yang X-C, Jing T-Y, Resnick LM, et al: Relation of hemostatic risk factors to other risk factors for coronary heart disease and to sex hormones in men. Arterioscler Thromb Vasc Biol 13:467-471, 1993
13. Phillips GB, Pinkernell BH, Jing T-Y: The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 14:701-706, 1994
14. Pi-Sunyer FX: Health implications of obesity. Am J Clin Nutr 53:1595S-S1603S, 1991
15. Ferrannini E, Haffner SM, Mitchell BD, et al: Hyperinsulinaemia: The key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416-422, 1991
16. Marin P, Andersson B, Ottosson M, et al: The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism 41:1242-1248, 1992
17. Bonora E: Relationship between regional fat distribution and insulin resistance. Int J Obes 24:S32-S35, 2000 (suppl 2)
18. Pouliot M-C, Despres J-P, Nadeau A, et al: Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 41:826-834, 1992
19. Tchernof A, Labrie F, Belanger A, et al: Relationship between endogenous steroid hormone, sex hormone-binding globulin and lipoprotein levels in men: Contribution of visceral obesity, insulin levels and other metabolic variables. Atherosclerosis 133:235-244, 1997
20. Olefsky J, Reaven GM, Farquhar JW: Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects. J Clin Invest 53:64-76, 1974
21. Glass AR, Swerdloff RS, Bray GA, et al: Low serum testosterone and sex-hormone-binding globulin in massively obese men. J Clin Endocrinol Metab 45:1211-1219, 1977
22. Schneider G, Kirschner MA, Berkowitz R: Increased estrogen production in obese men. J Clin Endocrinol Metab 48:633-638, 1979
23. Kley HK, Edelmann P, Kruskemper HL: Relationship of plasma sex hormones to different parameters of obesity in male subjects. Metabolism 29:1041-1045, 1980
24. Stanik S, Dornfeld LP, Maxwell MH, et al: The effect of weight loss on reproductive hormones in obese men. J Clin Endocrinol Metab 53:828-832, 1981
25. Randle PJ, Hales CN, Garland PB, et al: The glucose fatty-acid cycle: Its role in insulin sensitivity and the metabolic disturbance of diabetes mellitus. Lancet 1:785-789, 1963
26. Tsai EC, Boyko EJ, Leonetti DL, et al: Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men. Int J Obes 24:485-491, 2000
27. Haffner SM, Shaten J, Stern MP, et al: Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. Am J Epidemiol 143:889-897, 1996
28. Oh J-Y, Barrett-Connor E, Wedick NM, et al: Endogenous sex hormones and the development of type 2 diabetes in older men and women: The Rancho Bernardo Study. Diabetes Care 25:55-60, 2002
29. Ohlson L-O, Larsson B, Svardsudd K, et al: The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 34:1055-1058, 1985
30. Marin P, Holmang S, Jonsson L, et al: The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes 16:991-997, 1992
31. Rebuffe-Scrive M, Marin P, Bjorntorp P: Effect of testoterone on abdominal adipose tissue in men. Int J Obes 15:791-795, 1991
32. Boyko EJ, Leonetti DL, Bergstrom RW, et al: Low insulin secretion and high fasting insulin and C-peptide levels predict increased visceral adiposity. 5-year follow-up among initially nondiabetic Japanese-American men. Diabetes 45:1010-1015, 1996
33. Haffner SM, Stern MP, Mitchell BD, et al: Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes 39:283-288, 1990
34. Lillioja S, Mott DM, Spraul M, et al: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective study of Pima Indians. N Engl J Med 329:1988-1992, 1993
35. Swinburn BA, Nyomba BL, Saad MF, et al: Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest 88:168-173, 1991
36. Valdez R, Mitchell BD, Haffner SM, et al: Predictors of weight change in a bi-ethnic population. The San Antonio Heart Study. Int J Obes 18:85-91, 1994
37. Hoag S, Marshall JA, Jones RH, et al: High fasting insulin levels associated with lowe rates of weight gain in persons with normal glucose tolerance: The San Luis Valley Diabetes Study. Int J Obes 19:175-180, 1995
38. Schwartz MW, Boyko EJ, Kahn SE, et al: Reduced insulin secretion: An independent predictor of body weight gain. J Clin Endocrinol Metab 80:1571-1576, 1995
39. Bjorntorp P: The regulation of adipose tissue distribution in humans. Int J Obes 20:291-302, 1996
40. Bengtsson B, Eden S, Lonn L, et al: Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 76:309-317, 1993
41. Bujalska IJ, Kumar S, Stewart PM: Does central obesity reflect "Cushing's disease of the omentum"? Lancet 349:1210-1213, 1997
42. Phillips GB: Relationship of serum sex hormones to coronary heart disease. Steroids 58:286-290, 1993
43. Phillips GB: Sex hormones in male serum. Steroids 58:554-555, 1993 (comment)
44. Phillips GB, Pinkernell BH, Jing T-Y: Relationship between serum sex hormones and coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol 17:695-701, 1997
45. Imbeault P, Lemieux S, Prud'homme D, et al: Relationship of visceral adipose tissue to metabolic risk factors for coronary heart disease: Is there a contribution of subcutaneous fat cell hypertrophy? Metabolism 48:355-362, 1999
46. Seidell JC, Bjorntorp P, Sjostrom L, et al: Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 39:897-901, 1990
47. Lichtenstein MJ, Yarnell JWG, Elwood PC, et al: Sex hormones, insulin, lipids, and prevalent ischemic heart disease. Am J Epidemiol 126:647-657, 1987
48. Pasquali R, Casimirri F, Cantobelli S, et al: Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 40:101-104, 1991
49. Simon D, Preziosi P, Barrett-Connor E, et al: Interrelation between plasma testosterone and plasma insulin in healthy adult men: The Telecom Study. Diabetologia 35:173-177, 1992
50. Haffner SM, Karhapaa P, Mykkanen L, et al: Insulin resistance, body fat distribution, and sex hormones in men. Diabetes 43:212-219, 1994
51. Tchernof A, Despres J-P, Dupont A, et al: Relation of steroid hormones to glucose tolerance and plasma insulin levels in men. Diabetes Care 18:292-299, 1995
52. Caro JF: Insulin resistance in obese and nonobese man. J Clin Endocrinol Metab 73:691-695, 1991
53. Laakso M: How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959-965, 1993
54. Phillips GB: Evidence for hyperestrogenemia as the link between diabetes mellitus and myocardial infarction. Am J Med 76:1041-1048, 1984
55. Small M, MacRury S, Beastall GH, et al: Oestradiol levels in diabetic men with and without a previous myocardial infarction. QJM 243:617-623, 1987
56. Ando S, Rubens R, Rottiers R: Androgen plasma levels in male diabetics. J Endocrinol Invest 7:21-24, 1984
57. Barrett-Connor E: Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann Intern Med 117:807-811, 1992
58. Andersson B, Marin P, Lissner L, et al: Testosterone concentrations in women and men with NIDDM. Diabetes Care 17:405-411, 1994
59. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15:318-366, 1992
60. Megyesi C, Samols E, Marks V: Glucose tolerance and diabetes in chronic liver disease. Lancet 2:1051-1056, 1967
61. Nielsen J, Johansen K, Yde H: Frequency of diabetes mellitus in patients with Klinefelter's syndrome of different chromosome constitutions and the XYY syndrome. Plasma insulin and growth hormone level after a glucose load. J Clin Endocrinol Metab 29:1062-1073, 1969
62. Esptein CJ, Martin GM, Schultz AL, et al: Werner's syndrome. Medicine (Baltimore) 45:177-221, 1966
63. Huff TA, Horton ES, Lebovitz HE: Abnormal insulin secretion in myotonic dystrophy. N Engl J Med 277:837-841, 1967
64. Talaat M, Habib YA, Habib M: The effect of testosterone on the carbohydrate metabolism in normal subjects. Arch Int Pharmacodyn Ther 111:216-226, 1957
65. Friedl KE, Jones RE, Hannan CJ Jr, et al: The administration of pharmacological doses of testosterone or 19-nortestosterone to normal men is not associated with increased insulin secretion or impaired glucose tolerance. J Clin Endocrinol Metab 68:971-975, 1989
66. Polderman KH, Gooren LJG, Asscheman H, et al: Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab 79:265-271, 1994
67. Singh AB, Hsia S, Alaupovic P, et al: The effects of varying doses of T on insulin sensitivity, plasma lipids, apoliproteins, and C-reactive protein in healthy young men. J Clin Endocrinol Metab 87:136-143, 2002
68. Stuart CA, Prince MJ, Peters EJ, et al: Hyperinsulinemia and hyperandrogenemia: In vivo androgen response to insulin infusion. Obstet Gynecol 69:921-925, 1987
69. Ebeling P, Stenman U-H, Seppala M, et al: Acute hyperinsulinemia, androgen homeostasis and insulin sensitivity in healthy man. J Endocrinol 146:63-69, 1995
70. DeFronzo RA, Barzilai N, Simonson DC: Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. J Clin Endocrinol Metab 73:1294-1301, 1991
71. Ozata M, Oketenli C, Bingol N, et al: The effects of metformin and diet on plasma testosterone and leptin levels in obese men. Obes Res 9:662-667, 2001
72. Smith EP, Boyd J, Frank GR, et al: Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056-1061, 1994
73. Morishima A, Grumbach MM, Simpson ER, et al: Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80:3689-3698, 1995
74. Hermann BL, Saller B, Janssen OE, et al: Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J Clin Endocrinol Metab 87:5476-5484, 2002
75. Carani C, Qin K, Simoni M, et al: Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 337:91-95, 1997